 Altavo | Dresden medical-technology company developing an artificial voice for people who have lost speech, including after laryngectomy. Its non-invasive radar sensors detect silent articulation, while neural-network algorithms translate those signals into audible speech. The speech prosthesis is in development with research partners at TU Dresden. | |
 Alteryx | Alteryx operates in Data & Analytics. | |
 Althea, Inc. | Althea, Inc. operates in E-Commerce & Marketplace. | |
 Altis Biosystems | Company operating in Biotech & Life Sciences. | |
 Altis Labs | Develops AI endpoints that help pharmaceutical companies evaluate cancer treatments in clinical trials. Its IPRO model analyzes routine radiology scans to predict survival outcomes and identify treatment effects earlier, using models trained on longitudinal imaging, molecular, clinical and outcomes data. The platform supports analysis of Phase 1–4 oncology trials. | |
 Alto | Company operating in Mobility & Transportation. | |
 Alto Neuroscience | Alto Neuroscience, Inc. is a publicly listed, clinical-stage biopharmaceutical company developing precision treatments for neuropsychiatric disorders. Founded in 2019 by psychiatrist and neuroscientist Amit Etkin, its machine learning platform combines EEG brain activity, computerized cognition tests, wearable sleep and activity data, and clinical datasets to identify patient groups more likely to respond to particular drug candidates. Its investigational pipeline addresses major depressive disorder, treatment-resistant depression, bipolar depression and schizophrenia. The platform supports biomarker selection and drug development; the company’s candidates remain investigational. Alto completed its NYSE ANRO initial public offering in February 2024, followed by institutional private placements and a July 2026 registered direct offering. It is headquartered in Mountain View, California. | Mountain View, California, United States |
 AltoIRA | Company operating in Fintech. | |
 Altos Labs | Altos Labs researches cellular rejuvenation and develops potential medicines intended to restore cell health and resilience, with the aim of reversing disease, injury and age-associated disability. Its experimental biologists, drug-development teams and Institute of Computation combine cellular reprogramming research, machine learning and multi-scale generative models of cell and organ health to translate discovery into treatments. | |
 Altrina | | |
 Altris AI | AI-powered OCT scan interpretation for eye-care specialists. | |
 Altro | | |
 Altrove | Manufacturing company. | |
 Altruist | Company operating in Fintech. | |
 AltSchool | Education startup that built personalized learning schools; later restructured as Altitude Learning. | San Francisco, California |
 Altura | Infrastructure & Cloud company. | |
 Alude | | |
 Alva Energy | Company operating in Climate & Energy. | |
 Alvin | Company operating in AI. | |
 Alvys | Company operating in Logistics & Supply Chain. | |
 Alyce | Marketing & Advertising company. | |
 Alyce | | |
 ALZpath | ALZpath is a Carlsbad, California neuroscience diagnostics company founded in 2020. Its proprietary antibody detects blood phosphorylated tau 217 (pTau217), a biomarker of Alzheimer’s pathology, and is licensed to diagnostic and research platforms including Roche, Beckman Coulter, Siemens Healthineers, Abbott, Alamar Biosciences and Quanterix. ALZpathDx is offered through Neurocode as a laboratory-developed test; ALZpath’s patient information states this LDT is not FDA-approved or cleared. Roche’s separate Elecsys pTau217 diagnostic received FDA clearance in August 2026, which does not confer clearance on every assay using the antibody. These are diagnostic tools, not Alzheimer’s medicines or stand-alone proof of future disease or treatment response. CEO Mike Banville leads a four-person executive team, supported by six directors and eight scientific advisers. Its founders include Jerre Stead, Eric Reiman and former CEO Venkat Shastri. The October 7, 2026 Quanterix agreement expands research-platform licensing, rather than announcing equity investment. | Carlsbad, California, United States |
 AM Batteries | Company operating in Climate & Energy. | |
 AMADTEUS Technologies | AMADTEUS Technologies develops miniaturised and automated chemistry platforms for early drug discovery. It combines high-throughput synthesis and screening, acoustic nanolitre dispensing, multicomponent chemistry and computational methods to explore libraries of potential bioactive molecules while reducing reagent use and manual experimentation. The Hamburg company is a spin-off associated with Palacký University Olomouc and was co-founded within the IP Lab Ventures ecosystem. It has partnered with Accelerated Muscle Biotechnologies and Sarcometrics to apply accelerated discovery to cardiac and skeletal muscle therapies and supplements. | |
 Amae Health | Amae Health operates in Healthcare. | |
 Amagi | Amagi operates in Media & Entertainment. | |
 Amal Invest | | |
 Amari | AI company. | |
 Amber Bio | Company operating in Biotech & Life Sciences. | |
 Amber Therapeutics | Amber Therapeutics operates in Healthcare. | |
 Ambience | Ambience operates in Construction. | |
 Ambiq | Designs ultra-low-power processors and semiconductor systems that run AI and other computing functions in wearables, connected devices and battery-powered products. | |
 Ambit | Ambit Analytics developed speech-analysis software to help employees and managers improve workplace communication. Spun out of SRI International, it used acoustic analytics and personalized coaching to provide feedback on how people talk and listen. | |
 AMBOSS | AMBOSS operates in Education. | |
 ambr | Company operating in Gaming. | |
 Ambri | | |
 Ambro | Ambro operates in Manufacturing. | |
 Ambrook | Ambrook operates in Fintech. | |
 Ambrosia Energy | Ambrosia Energy builds vertically integrated solar + battery power plants in West Texas, supplying reliable 24-hour electricity at competitive rates with 99.9% uptime. | |
 Amca | Designs and manufactures highly engineered aerospace parts and subsystems—actuators, switches, hydraulics, and power electronics—by combining legacy suppliers with modern engineering. Headquartered in El Segundo, California. | El Segundo, California |
 AMEC | | |
 Amenitiz | Amenitiz is an all-in-one operating system for independent hotels and B&Bs, combining a cloud PMS, channel manager, native booking engine, website builder, and integrated payments to streamline operations and increase direct bookings. | 🇪🇸 · Spain |
 Amenli | | |
 American College of Cardiology | The American College of Cardiology (ACC) is a nonprofit cardiovascular professional society founded in1949, headquartered at Heart House in Washington, DC. It supports clinicians through education, research publishing, clinical guidelines, registries, accreditation and health-policy advocacy. Its January2026 bylaws identify the College as a District of Columbia nonprofit corporation exempt under Section501(c)(6). The related American College of Cardiology Foundation is a separate501(c)(3) corporation with ACC as its sole member; charitable gifts and educational grants support the Foundation. This institutional profile represents the named College rather than an independent venture manager. ACC’s relevance to AI is grounded in its Innovation Program, clinical AI resources and actual participation in Cleerly’s2021 SeriesB financing for AI-based coronary imaging. Its current published national leadership includes fifteen officers/trustees, eight executive staff leaders and Innovation Program chair Fred Masoudi. The executive directory identifies MedAxiom’s president and CEO as a subsidiary leader, rather than College CEO. Former innovation chief Ami Bhatt is explicitly reported to have departed for WHOOP in the September2026 magazine. Institution revenues, donations, endowment support and subsidiary governance are distinct from closed venture funds; no independent VC fund close or institutional fundraising round is verified here. | Washington, District of Columbia, United States |
 American Supercritical | American Supercritical develops modular systems that convert waste heat into electricity using supercritical carbon dioxide. | |
 American Terawatt | Develops high-voltage direct-current transmission infrastructure designed to deliver electricity to large industrial facilities, including AI data centers and semiconductor factories. | |
 AMI Labs | Frontier AI research company developing world models that learn abstract representations of sensor data, predict how environments evolve and support memory, reasoning and planning. Its action-conditioned models aim to let AI systems anticipate the consequences of actions and operate within safety constraints. It is researching applications in industrial process control, automation, wearable devices, robotics and healthcare, with teams in Paris, New York, Montreal and Singapore. | |
 AMI Paris | Company operating in Consumer. | |
 Amie | Amie operates in SaaS. | |
 Amigo | Healthcare company. | |
 Amini | Kenyan climate data infrastructure. | Nairobi, Kenya |
 Amino Apps | | |
 AminoChain | AminoChain operates in Healthcare. | |
 Amira Learning | Amira Learning develops AI-powered reading assessment and tutoring software for schools. Its system listens as students read aloud, identifies reading difficulties and provides feedback and instruction with teacher oversight. | |
 Amitree | Amitree operates in Enterprise Software. | |
 Ammobia | Develops modular ammonia-production systems intended to lower manufacturing costs and support low-carbon chemical and energy supply chains. | |
 AMMP | AMMP provides AMMP OS, a device-agnostic platform that connects and manages clean‑energy portfolios. By aggregating data from diverse hardware and sites into a single, actionable view, it helps energy companies automate operations, reduce downtime, and scale reliably. | 🇳🇱 · Netherlands |
 Amobee | Amobee is an advertising technology platform for audience planning, cross-channel media activation and analytics, acquired by Tremor International in 2022. | |
 Amodo | Company operating in Insurance. | |
 Amp | Amp operates in Consumer. | |
 AMP Robotics | | |
 AMPECO | Company operating in Mobility & Transportation. | |
 Amperecloud | Amperecloud builds the operating system for renewables: a central hub that connects data loggers, inverters, and meters to deliver real-time monitoring, anomaly detection, and reporting across solar portfolios. The platform streamlines operations so asset owners maximize yield and uptime. | 🇩🇪 · Germany |
 Amperesand | Company operating in Hardware & Semiconductors. | |
 Ampersand | Ampersand operates in Developer Tools. | |
 Amplemarket | Amplemarket provides an AI-powered sales platform for prospecting, multichannel outreach and go-to-market workflow automation. | |
 Amplication | Developer Tools company. | |
 Amplifier Therapeutics | | |
 Amplifold | Amplifold operates in Marketing & Advertising. | |
 Amplitude | | |
 Amplitude, Inc. | Amplitude operates in Data & Analytics. | San Francisco, CA, USA |
 Ampsortation | | |
 AMSL Aero | Company operating in Mobility & Transportation. | |
 Amunix | | |
 Amunix Pharmaceuticals | | |
 Amydis | Clinical-stage biotechnology company developing small-molecule fluorescent ocular tracers to detect disease-related proteins through standard eye imaging. Its research targets amyloid beta, alpha-synuclein, tau, TDP-43 and other molecular biomarkers linked to neurodegenerative, ophthalmic and cardiovascular disorders. Amydis combines tracer chemistry, retinal imaging and AI-based analysis of molecular biomarker patterns, including a 2026 NIH-supported TDP-43 program for ALS, frontotemporal dementia and LATE. Its diagnostic candidates remain investigational; human clinical studies do not establish an approved screening test or treatment for Alzheimer's disease or Parkinson's disease. Stella Sarraf founded Amydis in 2013. The company has corporate offices in Los Angeles and a laboratory in La Jolla and was previously named Amydis Diagnostics Inc. Its public funding includes NIH and Michael J. Fox Foundation research grants and three SEC-disclosed private securities offerings in 2022-2023. Grant budgets, offering targets and amounts actually sold are recorded separately. | Los Angeles, California, United States · La Jolla, California, United States |
 Amylyx Pharmaceuticals | | |
 Amyris | Company operating in Biotech & Life Sciences. | |
 Anaconda Biomed | Anaconda Biomed S.L. is a Barcelona-area medical-device company developing funnel-based endovascular access and protection technology for neurovascular interventions, including mechanical thrombectomy in acute ischemic stroke caused by large-vessel occlusion. Co-founded in2015 by neurologist Marc Ribó and biomedical materials scientist Ofir Arad, it is registered in Spain under tax numberB66513474 and manufactures in Sant Quirze del Vallès. Its platform combines a self-expanding nitinol funnel, aspiration and temporary vascular-flow restriction, with devices intended to support clot retrieval and reduce downstream embolization. Clinical outcomes remain subject to the relevant product studies and indications. The issuer identifies ANA5 as CE-mark approved and the ANA Funnel Catheter as investigational-only in the United States. Its ongoing ATHENA pivotal IDE study is a prospective randomized327-subject trial. Trent Reutiman leads the company asCEO, alongside a published eight-person management team, external clinical scientific advisers and board representatives from its specialist healthcare investors. A closedUSD56M financing announced September23,2026 supports clinical development, manufacturing and regulatory work; the record separately identifies prior equity financings, investment commitments, public grant support and its signed EIB venture-debt facility. | Sant Quirze del Vallès, Barcelona, Spain |
 Anagram | Healthcare company. | |
 Anakin | AI company. | Austin, TX, US |
 Anakin | | |
 Anaqua | Anaqua operates in Legal. | |
 Anari | | |
 Anaxis Pharma | Anaxis Pharma is an Australian biotechnology company developing small-molecule inhibitors and modulators of necroptosis, an inflammatory form of programmed cell death involving kinases and pseudokinases. Its discovery programs seek treatments for acute and chronic inflammatory diseases, including inflammatory bowel disease, Crohn’s disease, liver fibrosis and reperfusion injury. The company combines Walter and Eliza Hall Institute biological and structural-research expertise with SYNthesis Research medicinal chemistry, conducting hit-to-lead work, lead optimisation, screening and preclinical candidate selection. It describes two preclinical programs supported by pharmaceutical partners. SYNthesis BioVentures identifies Anaxis as the wholly owned main operating subsidiary of Catalyst Therapeutics. Published plans to advance candidates towards clinical studies are not evidence that human trials have started or that a medicine is approved. | Parkville, Melbourne, Victoria, Australia |
 Ancana | | |
 AnChain.AI | AnChain.AI operates in Crypto & Web3. | |
 Anchor | | |
 Anchorage Digital | Anchorage Digital operates in Crypto & Web3. | |
 Ancient Nutrition | Company operating in Consumer. | |
 Ancilia Biosciences | Ancilia Biosciences uses CRISPR-based protection against bacteriophages to develop more durable live bacterial therapeutics and microbial products. | |
 Ancora Biotech | Bispecifics for B-cell cancers, metabolic disease, and HBV. Founded 2021. Palo Alto. Later acquired by AstraZeneca. | Palo Alto, California |
 Andalusia Labs | | |
 Andera | AI-native platform that automates internal audit, including end-to-end control testing across SOX, operational, and compliance controls. | San Francisco, California |
 Andercore | Company operating in Enterprise Software. | |
 Andersen Advisory Group A/S | Andersen Advisory Group A/S is a privately owned Danish corporate holding, advisory and investment company, CVR 15273771. Its original 2025 annual filing, approved on 12 June 2026, identifies the registered office at Søllerødvej 30, 2840 Søllerød/Holte, and separate parent Moesgaard Consulting ApS. It is distinct from that parent, Andersen Advisory Group Invest A/S and other Andersen consultancies. The filing has an extended-review assurance report rather than a full audit. The group's archived website reports establishment in 1991 as the holding company of Andersen Management International A/S, an IT/telecommunications consultancy.
Its own website, archived in March 2024, describes private venture/equity investment in new and established businesses with a focus on cloud software. It combines capital with strategy, marketing, financial management, technology development, project management and recruitment advice. Michael Moesgaard Andersen is its published ultimate owner and active investment principal; personal ownership remains distinguished from the separate legal parent. The website is currently unavailable: HTTP returns 410 Gone and HTTPS has a hostname-certificate mismatch. Archived content and media are explicitly historical, and the old Copenhagen office is distinguished from the 2026 filing address.
The signed 2025 filing identifies CEO and board member Michael Moesgaard Andersen, board chair Flemming Poulfelt and board member Helle Andersen. It lists Danish Mobile Technology A/S as a subsidiary, and capital interests in Konsolidator A/S, Valuer Holding A/S and Configit Holding A/S. These are source-verified holdings, not proof of newly completed rounds, exact subscription dates or tickets. The archived own portfolio also names Penneo. Current Valuer primary sources describe AI engineering, predictive analytics, NLP, clustering and generative-AI business insights; Konsolidator's own product release documents AI account mapping. Relevant operating-company profiles and their holding/brand legal bridges require separate full verification.
Configit's September 2016 issuer publication identifies Andersen Advisory Group as its earlier main investor when moving offices in 2008. Its 4 February 2016 transaction announcement says former owners retained co-ownership after Polaris bought 65%, with price undisclosed. This is retained historical ownership, not an assumed new 2016 Andersen subscription, attribution of the entire remaining 35%, or a Michael personal cash check. Accounting share capital, securities, carrying values, corporate equity and dividends are not fresh investment tickets or fund closes.
Three publicly named leadership people and four capacities are established by the latest original annual filing. Michael's genuine archived own portrait and Flemming's university portrait were visually verified. Helle's expanded professional biography, authentic portrait and exact appointment date remain unpublished in the audited sources; no family relationship is inferred. The group's logo is original archived company media. Subsidiary employees and outside academic roles are not represented as holding-company staff. No primary source verifies an external-LP fund or fundraising close, and no such fund is invented. Missing relevant portfolio companies are queued for complete enrichment rather than created as bare placeholders. | Søllerødvej 30, 2840 Søllerød / Holte, Denmark (original2025 filing approvedJune2026) · Kristianiagade 7, 2100 Copenhagen Ø, Denmark (historical archived2024 website) |
 Andesite | Cybersecurity company. | McLean, VA, US |
 Andjaro | Andjaro operates in Logistics & Supply Chain. | |
 Andon Labs | | |
 Andrena | Andrena operates in Biotech & Life Sciences. | |
 Andromeda Surgical, Inc. | | |
 Anduril | Defense products company building autonomous systems for the U.S. and allies. Founded 2017. Costa Mesa, California. | Costa Mesa, California |
 Anduril Industries | | |
 ANELLO Photonics | ANELLO Photonics operates in Hardware & Semiconductors. | Santa Clara, CA, US |
 Anfin | | |
 Angel Host | Company operating in Travel & Hospitality. | |
 Angel.ai | Chatbot platform. | New York, New York |
 Angels Santé | Angels Santé is a French nonprofit healthcare business-angel network, legally Business Angels Santé / Health Angels France, declared under the1901 association law on March14,2008 and published in JOAFE April12,2008; SIREN504403353, own legal page SIRET50440335300023. It connects healthcare-expert individual investors with early-stage biotech, medtech, diagnostics and digital-health businesses, coordinating selection, due diligence, syndication, training and support. Individual business angels invest their own assets; this organization’s Investor profile represents the explicitly published network-mediated investment attribution, not proof of association-treasury principal cash or a single legal syndicate ticket. Current own roster names three operational staff, twelve nonprofit directors including three founders, and three Boston representatives of the Angels Santé USA network branch; volunteer/director/affiliate roles are distinct from employees. Corporate members and ecosystem partners are not automatically association investors or staff. The portfolio includes AI/digital-health, advanced diagnostics and neurodegeneration research, including HuntX Pharma. No externally closed LP fund or association-principal allocation is established from current own sources; cumulative member-investment statistics are not fund capital. Angels Santé Création, a separately named historical investment company, is not automatically the same legal association or buyer. | Paris, France · Boston, Massachusetts, United States (network branch) |
 Angitia Biopharmaceuticals | Angitia Biopharmaceuticals develops clinical-stage therapies for musculoskeletal diseases including osteoporosis and osteogenesis imperfecta. | |
 Angle | DeFi stablecoin protocol (Angle Labs). | France |
 Angle Health | Company operating in Healthcare. | |
 Anglehealth | | |
 Anglehealth | | |
 Anima | Company operating in Developer Tools. | |
 Anima App | Company operating in Developer Tools. | |
 Anima Health | Company operating in Healthcare. | |
 Animall | Company operating in Food & Agriculture. | |
 Anine Bing | Consumer company. | |
 Ankar | Agentic IP / patent-filing AI platform founded by Palantir alumni. | |
 Ankar AI | Ankar AI operates in AI. | |
 Anki | Anki operates in Education. | |
 Ankler Media | Ankler Media publishes subscription newsletters, podcasts and events covering Hollywood and the entertainment business. | |
 Ankorstore | Ankorstore operates in E-Commerce & Marketplace. | |
 Annea | AI company. | |
 Annexon Biosciences | | |
 Annexon Biosciences | Annexon Biosciences develops therapies targeting C1q and the classical complement pathway for neuroinflammatory diseases affecting the body, brain and eye. | |
 Anode | Hardware & Semiconductors company. | |
 Anodyne Nanotech | Anodyne Nanotech is a Boston biotechnology company developing transdermal delivery systems for chronic medicines. Its HeroPatch contains solid porous microneedles loaded with drug molecules; after application, fluid in the skin releases the medicine by diffusion while the needle structures remain intact and are removed with the patch. The platform is designed for multi-milligram doses of peptides and biologics, adjustable release profiles and solid-state formulations that reduce cold-storage requirements. Its development pipeline includes ANN-101, a once-weekly GLP-1 receptor agonist patch for obesity, ANN-102 targeting the APJ receptor for muscle loss, and a combined GLP-1/APJ program for sarcopenic obesity. These are development candidates rather than approved therapies. | |
 Anomali | Cybersecurity company. | Redwood City, CA, United States |
 Anomalo | Enterprise Software company. | |
 AnotherBrain | AnotherBrain operates in AI. | |
 Anrok | Company operating in Fintech. | |
 Ansa | Ansa operates in Fintech. | |
 Ansa | | |
 Ansa Biotechnologies | Enzymatic DNA synthesis company building longer, more accurate custom DNA for biology. | Emeryville, California |
 Ansel | Consumer company. | |
 Ansible | Developer Tools company. | |
 Ansible Labs | Fintech company. | San Francisco, CA, US |
 AnswerThis | | |
 Ant Financial Services Group | | |
 Antares | Nuclear microreactors for defence and space. | Torrance, CA, US |
 Antares Pharma | Antares Pharma developed and commercialized specialty pharmaceutical products using proprietary injection and transdermal drug-delivery systems; Halozyme acquired it in 2022. | |
 Antares Therapeutics | Precision medicines company spun out of Scorpion Therapeutics, developing first-in-class small-molecule drugs for cancer and other serious diseases. Launched in 2025. Headquartered in Boston. | Boston, Massachusetts |
 Antaris | Defense & Space company. | |
 Antenova | Antenova operates in Hardware & Semiconductors. | |
 Anterior | | |
 Anthrogen | Anthrogen operates in Biotech & Life Sciences. | |
 Antidote | Company operating in Healthcare. | |
 Antimatter | Unlocking mastery through memes, puzzles, and games | |
 Antimatter | | |
 Antithesis | Antithesis operates in Cybersecurity. | |
 Antiva Biosciences | Company operating in Biotech & Life Sciences. | |
 Antora | Climate & Energy company. | |
 Antora Energy | Builds zero-carbon thermal batteries that store renewable electricity as heat for industrial processes and power. | Sunnyvale, California |
 Antwalk | | |
 Anvil | Developer Tools company. | San Francisco, CA, US |
 Anvil Robotics | Builds configurable robotic hardware and open-source development tools that let physical-AI teams prototype and deploy robot systems without designing every component from scratch. | |
 Any.do | SaaS company. | |
 ANYbotics | ANYbotics operates in Robotics & Automation. | |
 Anycart | Anycart developed a grocery-shopping platform that connected recipes with online grocery baskets. Shoppers could select meals, buy ingredients from participating retailers and follow guided cooking videos in one place. | |
 Anyfin | Swedish loan-refinancing fintech. Founded 2017. | Stockholm, Sweden |
 Anyline | Company operating in AI. | |
 AnyRoad | Marketing & Advertising company. | |
 Anyscale | Anyscale operates in AI. | |
 Anysignal | Company operating in Telecom. | |
 Anysphere | Anysphere operates in AI. | |
 Anything | Anything operates in AI. | |
 Anything AI | Anything AI operates in AI. | |
 Anytype | Anytype operates in Developer Tools. | |
 Anzen | Anzen operates in Crypto & Web3. | |
 AOA Dx | AOA Dx develops blood-based diagnostics for early detection of ovarian cancer using glycolipid biomarkers and its GlycoLocate platform. | |
 apaleo | Enterprise Software company. | |
 Apate AI | Apate AI operates in Cybersecurity. | |
 Apeel | Apeel operates in Food & Agriculture. | |
 Apellis Pharmaceuticals | Develops and commercialises medicines that inhibit the complement immune system, including treatments for geographic atrophy and paroxysmal nocturnal haemoglobinuria. Biogen completed its acquisition of Apellis on 14 May 2026. | |
 ApertureData | Company operating in Data & Analytics. | |
 Apeteat | Apeteat operates in Food & Agriculture. | |
 Apex | Apex operates in Defense & Space. | Los Angeles, CA, US |
 Apex.AI | Software company providing development kits, AI tools and engineering services for autonomy and software-defined systems. | |
 Apexx | | |
 apheris AI | Company operating in Data & Analytics. | |
 Apiday | Company operating in SaaS. | |
 Apify | Data & Analytics company. | Prague, CZ |
 Apiiro | Cybersecurity company. | |
 Apixio | | |
 APN LifeSciences | Diagnostics branch of APRINOIA Therapeutics developing tools for early detection and differentiation of neurodegenerative diseases. It develops the APN-1607 (florzolotau) tau PET imaging tracer and works on blood tests, brain-focused PET systems and AI image interpretation. It aims to combine these technologies in a brain-health management platform for disease staging, monitoring and personalized care. Its published pipeline lists the tracer in Phase III development for Alzheimer’s disease in China; its June 2025 release describes ongoing regulatory review in Taiwan. | |
 Apna | | |
 Apoha | Company operating in Healthcare. | |
 Apolink | Apolink operates in Defense & Space. | |
 Apolitical | Company operating in Government & Civic. | |
 Apollo | Company operating in SaaS. | |
 Apollo | Apollo Neuro develops a wearable device that delivers gentle vibrations intended to support stress management, sleep and focus. | |
 Apollo | | |
 Apollo Atomics | | |
 Apollo Research | Independent research organization evaluating AI systems for deceptive and misaligned behavior. Became a public benefit corporation. | London, United Kingdom |
 ApolloShield | | |
 Aporeto | Cybersecurity company. | |
 App Annie | | |
 App Annie | | |
 App Annie Inc. | | |
 Appboxo | SaaS company. | |
 AppBoy | | |
 Appbrew | Appbrew operates in Consumer. | |
 Appcard | Company operating in Marketing & Advertising. | |
 Appcelerator | Company operating in Enterprise Software. | |
 Appcharge | Fintech company. | |
 Appcues | Company operating in SaaS. | |
 AppDirect | Company operating in Enterprise Software. | |
 Appdome | | |
 AppDynamics | | |
 Appear Here | Appear Here operates in PropTech. | |
 AppFollow | Company operating in Developer Tools. | |
 AppHero | SaaS company. | |
 Appia Bio | Appia Bio operates in Biotech & Life Sciences. | |
 Appier | | |
 Appirio | | |
 Appital | Fintech company. | |
 Applied Cognition | Applied Cognition Inc. is a private neuroscience and biomedical technology company in Redwood City, California developing noninvasive measurement of human glymphatic function and investigational treatments directed at brain waste clearance. Its sensor and research platform measures physiological features associated with sleep-active clearance of amyloid beta, tau and other metabolites. The company combines biomedical engineering, neuroscience, clinical research, algorithms and data science; its published mission includes building a dataset for future AI integration in therapeutic discovery. Its pipeline includes investigational ACX-02 and exploratory ACX-14 programs targeting glymphatic mechanisms relevant to Alzheimer’s disease, Parkinson’s disease and post-traumatic headache. Peer-reviewed human studies and a March 2026 preprint report physiological and biomarker findings; these are not proof of disease prevention or regulatory approval. The current public leadership directory names co-founders Paul Dagum and Jake Winebaum. Additional research affiliations are qualified against dated scientific publications. Primary investor portfolios verify backing from GreyMatter Capital, Mayfield, What If Ventures, Supermoon Capital and A&E Investments; exact company cash financing amounts, stages and closing dates remain undisclosed in reviewed primary sources. An MTEC technology showcase also confirms a government-sponsored research award, with its amount, award date and precise legal sponsor unverified. | Redwood City, California, United States |
 Applied Intuition | Applied Intuition operates in Robotics & Automation. | Sunnyvale, CA, US |
 Applied Molecular Evolution | Biotechnology company listed on Goldi Founders Fund portfolio. | |
 Applied Systems | | |
 AppliedAI | AppliedAI develops AI workflow systems for regulated industries including healthcare, insurance, banking and government. Its Opus platform helps enterprises discover, build, run and optimize document-intensive operational processes using AI agents, human oversight, audit trails and governance controls. Headquartered in Abu Dhabi, the company serves organizations across international markets. | |
 AppliedVR | Los Angeles-based immersive therapeutics company developing virtual reality products for pain management. Its prescription RelieVRx device, formerly EaseVRx, delivers an eight-week program incorporating cognitive behavioral skills, breathing and mindfulness for adults with chronic low back pain. The FDA granted EaseVRx De Novo marketing authorization in November 2021; this does not establish authorization for other conditions. The company's SustainVR product is a general wellness device offered within the US Department of Veterans Affairs. Founded in 2015, AppliedVR combines behavioral science, neuroscience and medical-device engineering, with research programs supported by NIH SBIR awards. It announced a USD29 million Series A in March 2021 and a USD36 million Series B in November 2021. Research partnerships, reimbursement and cumulative financing totals are distinct from individual funding rounds. | Los Angeles, California, United States |
 Applitools | Applitools operates in Developer Tools. | |
 AppLovin | Reach over a billion daily users in mobile games. AppLovin helps consumer brands and gaming apps scale their business profitably. | |
 Apply Design | | |
 AppMap | Company operating in Developer Tools. | |
 AppNeta | AppNeta is a SaaS network-performance monitoring platform that gives distributed enterprises end-to-end visibility into application and network experience; Broadcom acquired it in 2022. | |
 Apportable | | |
 Appsmith | Appsmith operates in Developer Tools. | |
 Apptimize | | |
 Apptio | Apptio operates in Enterprise Software. | |
 Apptronik | Builds humanoid robots, including Apollo, designed to perform physical tasks in manufacturing, logistics and other workplaces. | |
 Appurify | Developer Tools company. | |
 Appwrite | Company operating in Developer Tools. | |
 Appy Ai | AI company. | |
 AppZen | | |
 Apreo Health | | |
 Apreo Health | | |
 Apres | Social & Community company. | |
 APRINOIA Therapeutics | Neuroscience biotechnology company founded in 2015 that develops diagnostic imaging agents and targeted therapies for neurodegenerative disorders, including Alzheimer’s disease and related tauopathies. Its research programs target abnormal brain proteins through PET tracers, antibodies and protein-degradation approaches. Its diagnostics branch, APN LifeSciences, works on tau imaging and AI-assisted brain-health diagnostics. APRINOIA’s October 2026 website describes continued diagnostic and therapeutic work while announcing forthcoming updates. | |
 Apriora | Apriora built an AI interviewer for real-time candidate screening and recruiting workflow automation; the product was subsequently rebranded as Alex. | US |
 Apron | Apron operates in Fintech. | |
 Apryl | Apryl operates in Healthcare. | |
 AptDeco | | |
 AptEdge | Company operating in Enterprise Software. | |
 Aptem | Company operating in HR & Talent. | |
 Aptinyx | Company operating in Biotech & Life Sciences. | |
 Aptonomy Inc. | Aptonomy developed autonomous security drones that patrol sites and respond to alarms using onboard perception and navigation systems. | |
 Aqemia | Biotech & Life Sciences company. | |
 AQMetrics | Data & Analytics company. | |
 Aqqrue | Builds an AI workspace for accounting and bookkeeping firms. Its agents connect to accounting software and client documents to prepare journal entries, reconcile accounts, clean historical books and execute closing checklists. Accountants review the work and use the resulting financial information to advise their clients. | |
 Aqua Membranes | Aqua Membranes develops and manufactures reverse osmosis membrane elements for industrial water purification and reuse. Its patented Printed Spacer Technology prints three-dimensional features directly onto membrane surfaces, replacing the conventional plastic mesh spacer inside spiral-wound elements. The redesigned flow channels reduce pressure losses and fouling, helping operators lower energy use, increase water recovery and reduce cleaning interruptions. Its membrane elements fit existing reverse osmosis equipment, allowing facilities to upgrade filtration performance without replacing the whole system. The company serves semiconductor manufacturing, mining, power generation, food and beverage processing and water recycling, and provides engineering consultation, system-design software and an operating-cost calculator. | |
 Aqua Security | Cybersecurity company. | |
 Aquafortus | Climate & Energy company. | |
 Aquant | | |
 Aquant | | |
 Aquantia | | |
 AquaPoro | Atmospheric water harvesting in low humidity. | |
 Aquarium | | |
 Aradigm | Aradigm operates in Healthcare. | |
 Arago | AI company. | |
 Aranya | Aranya Inc operates in Infrastructure & Cloud. | |
 Araris Biotech | Company operating in Healthcare. | |
 Aravolta | Aravolta operates in Infrastructure & Cloud. | |
 Arbe Robotics | Radar-technology company developing four-dimensional imaging radar for autonomous vehicles and driver-assistance applications. | |
 Arbe Robotics | | |
 Arbital Health | Healthcare company. | |
 Arbitrum | | |
 Arbo Works | | |
 Arbonics | Company operating in Climate & Energy. | |
 Arbor | Climate & Energy company. | |
 Arbor Biotechnologies | Arbor Biotechnologies develops next-generation gene-editing medicines for genetic diseases of the central nervous system and liver. Its programmable DNA editors support gene knockout, excision, reverse-transcriptase editing and large-gene insertion, matched to individual disease mechanisms. Its CNS pipeline targets amyotrophic lateral sclerosis, frontotemporal dementia and Alzheimer’s disease. Its liver program ABO-101 is being evaluated in the RedePHine Phase 1/2 study for primary hyperoxaluria type 1. | Cambridge, MA, United States |
 Arbor Networks | | |
 Arborea | Arborea develops a photosynthesis-based production system for food proteins and functional ingredients. Its BioSolar Leaf technology cultivates microorganisms using sunlight and carbon dioxide to produce ingredients with less land and resource use. | |
 ARC | | |
 Arc | Arc operates in Crypto & Web3. | |
 Arc | | |
 Arc Boat Company | Consumer company. | |
 ARC Intelligence | Berlin company developing AI software that connects operational business data and automates analysis and reporting for small and medium-sized enterprises. Its platform integrates fragmented company systems and supports decisions using financial and operational data. | |
 ARC Prize Foundation | | |
 Arc Technologies | Fintech company. | |
 Arc Technologies, Inc. | | |
 Arcade | Company operating in AI. | |
 Arcadia | Arcadia operates in Climate & Energy. | |
 Arcadia Power | Arcadia Power operates in Climate & Energy. | |
 ARCEO | AI insurance underwriting (Arceo.ai). | San Francisco, California |
 Archbee | Developer Tools company. | |
 Archean | Archean, operated by AIMATX Inc., develops new materials by combining AI design with laboratory synthesis and physical validation. It starts with the performance, manufacturing and cost constraints of an industrial application, designs a matching material and synthesis route, makes the material, and tests it under real operating conditions. Its technical origins are in UC Berkeley’s Bakar Institute of Digital Materials for the Planet. Earlier work under the AIMATX name focused on metal-organic and covalent-organic frameworks for applications such as carbon capture, water absorption and drug delivery. The company supplies validated materials and products rather than requiring customers to test lists of computational candidates themselves. | |
 Archestra | Company operating in AI. | |
 Archetype AI | Develops physical AI software that interprets sensor data, video and operational context to understand real-world systems. Its Newton foundation model powers agents for anomaly detection, asset health, process monitoring and task verification across manufacturing, energy, construction, logistics and infrastructure. The Archetype platform and Agent Toolkit enable deployment in the cloud, on premises or at the edge, with adaptation to customers’ equipment and workflows. | |
 Archie | Developer Tools company. | |
 Archil | Infrastructure & Cloud company. | |
 Architect Labs | Company operating in Hardware & Semiconductors. | |
 Archive | | |
 Archive | | |
 Archive Intel | Fintech company. | Alpharetta, GA, US |
 Archive.AI | Company operating in Enterprise Software. | |
 Archlet | Archlet operates in Enterprise Software. | |
 Archy | Archy operates in PropTech. | San Jose, CA, US |
 Arcjet | Company operating in Cybersecurity. | |
 ArcPrime | Company operating in Enterprise Software. | |
 Arctic Wolf | | |
 Arctus Aerospace | Company operating in Defense & Space. | |
 Arculus | Arculus operates in Crypto & Web3. | |
 Arcutis | | |
 Arcutis Biotherapeutics | | |
 Arda Therapeutics | Arda Therapeutics operates in Biotech & Life Sciences. | |
 Ardent | Climate & Energy company. | |
 Ardent AI | AI company. | |
 Arduino | Arduino operates in Hardware & Semiconductors. | |
 Area 1 Security | Cybersecurity company. | |
 Arena | AI hardware engineer (Atlas) for electronics testing. $30M Series B with Founders Fund. | New York, New York |
 Arena | | |
 Arena | | |
 Arena Ai | AI company. | |
 Arena Club | | |
 Ares Industries | | |
 Ares Intelligence | Ares runs AI interviews across your entire workforce to discover what's broken and distills hundreds of conversations into a clear, intelligent path forward. | |
 Areteia Therapeutics | | |
 Arevo | Farming is unpredictable. Our arginine-powered crop nutrition works with plant biology to activate roots, help growers produce more with less. | |
 Arf | Provides working-capital liquidity for cross-border payment institutions. | Switzerland |
 Arga Labs | AI company. | |
 Argent | Argent operates in Crypto & Web3. | |
 Argilla | Company operating in Data & Analytics. | |
 Argo | | |
 Argobio Studio | Argobio Studio is a Paris-based operational biotechnology venture builder established in 2021. It sources early therapeutic projects from European academic research, co-founds and invests in companies, and embeds drug discovery, development and business expertise to advance them toward seed and Series A financing. Its programs span neuroscience, rare diseases, oncology and immunology. Its portfolio includes Elkedonia's ELK1-targeted depression program, alongside RNA, gene-therapy and protein-degradation platforms. | |
 Argon AI | AI software company providing research and analysis tools for pharmaceutical, biotechnology and life-sciences teams. | |
 Argus Systems | Company operating in Robotics & Automation. | |
 Argyle | | |
 Arialys Therapeutics | Arialys Therapeutics is a La Jolla, California clinical-stage biotechnology company developing precision medicines for autoimmune neuropsychiatric disorders. It combines structural biology, receptor pharmacology and sensitive autoantibody detection to identify and block pathogenic antibodies in the central nervous system. Its lead investigational candidate ART5803 is a humanized monovalent monoclonal antibody designed to inhibit NMDA receptor autoantibodies in anti-NMDA receptor encephalitis and related autoimmune psychosis. Following healthy-volunteer Phase 1 studies, the company reported patient dosing in a Korean open-label Phase 2a study and FDA clearance for a separate randomized US Phase 2 study in June 2026. Arialys was founded by Avalon BioVentures, Catalys Pacific and MPM BioImpact, and purchased ART5803 from Astellas Pharma. The therapy remains investigational; trial clearance and regulatory designations do not establish approved efficacy. | |
 Ariglad | | |
 Aril Inc | | |
 Arine | Arine operates in Healthcare. | |
 Ario | Ario develops a personalized AI assistant that connects to users' apps and information to help organize everyday tasks. It focuses on proactive assistance, including household scheduling and recommendations, while keeping users' connected data private. | |
 ARIS MACHINA | Robotics & Automation company. | Stockholm, SE |
 Arist | | |
 Arive | Instant delivery beyond groceries. | India |
 Arivihan | Arivihan operates in Education. | |
 Arize AI | Arize AI develops observability and evaluation infrastructure for AI applications, including large language models, agents, multimodal systems and traditional machine learning. Its managed Arize AX platform and open-source Phoenix library let engineering teams trace application behavior, run evaluations, inspect failures, compare experiments and monitor production performance. These tools help teams diagnose model drift, hallucinations and unreliable agent behavior, then improve prompts, models and workflows using evidence from development and production. Phoenix integrates with OpenTelemetry and OpenInference instrumentation. Dynatrace completed its acquisition of Arize on October 1, 2026; Arize continues to provide its AI engineering products within Dynatrace. | |
 Ark Robotics | Ark Robotics operates in Crypto & Web3. | |
 Arkero | Arkero operates in Climate & Energy. | |
 arketa | SaaS company. | |
 Arkuda Therapeutics | Arkuda Therapeutics, Inc. is a US biotechnology company founded in 2018 by Atlas Venture, Gerhard Koenig and Duane Burnett, historically based in Cambridge and subsequently Watertown, Massachusetts. It developed brain-penetrant small-molecule enhancers of progranulin and lysosomal function for neurodegenerative diseases, initially GRN-related frontotemporal dementia and potentially Alzheimer’s and Parkinson’s disease. ARKD-104 was described in July 2023 as an investigational IND-enabling development candidate; an expected trial start is not proof that clinical trials subsequently began or that the therapy demonstrated efficacy. Arkuda announced a USD44 million Series A in November 2019 and a USD64 million Series B in February 2022. In February 2024 it entered an option and asset purchase agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, involving an undisclosed commercial option payment and a separate equity investment from Johnson & Johnson Innovation–JJDC, Inc. In January 2025 Johnson & Johnson exercised the option to buy Arkuda’s portfolio of lysosomal function enhancers, with an undisclosed upfront payment and potential milestone payments. This was a portfolio asset transaction; the announcement does not establish acquisition of the Arkuda legal company. Its investors classify the holding as exited. Historical leadership and scientific staff are sourced to original archived company biographies and dated announcements, without asserting continued employment after the asset sale. Gerhard Koenig became CEO of Augustine Therapeutics in January 2025; Serena Hung joined Atalanta Therapeutics in May 2024. Arkuda’s former arkudatx.com domain now serves unrelated content and is not listed as a current company website. Current standalone operating status and a replacement official domain are unverified. Its relevance is neuroscience and drug discovery; no AI platform, approved treatment or undisclosed transaction value is inferred. | Watertown, Massachusetts, United States · Cambridge, Massachusetts, United States (historical) |
 Arlequin | Arlequin operates in Consumer. | |
 Arlo | Hardware & Semiconductors company. | |
 Armada | Edge computing and communications for remote operations (defense, energy, disaster). Founded by Dan Wright. | Seattle, Washington |
 Armada Interactive | Armada Interactive operates in Gaming. | |
 Armadin | Armadin operates in Cybersecurity. | |
 Armilla | | |
 Armilla AI | | |
 Armis | | |
 Armis Security | Real-time CVE vulnerability intelligence with AI-driven risk scoring, early warnings, and industry impact analysis. Powered by Armis. | |
 Armo BioSciences | | |
 ArmorCode | Company operating in Cybersecurity. | |
 Armored Things | Company operating in Cybersecurity. | |
 Armory | | |
 Armory Medical | Develops AI infrastructure that handles administrative and operational work across the patient lifecycle, aiming to free clinicians to deliver care and reduce delays in accessing treatment. | |
 Armory, Inc. | | |
 Arnergy | Arnergy operates in Climate & Energy. | |
 Aro Homes | Company operating in Construction. | |
 Arpari | | |
 Arpeggi Labs | Arpeggi Labs operates in Crypto & Web3. | |
 Arpeggio | Company operating in Biotech & Life Sciences. | |
 Arpeggio Bio | Drug-discovery company that maps RNA dynamics to find new medicines. | Boulder, Colorado |
 Arpio | | |
 ARQ | Latin American fintech (formerly DolarApp) for multi-currency accounts. Sequoia and Founders Fund backed $70M in March 2026. | Mexico City, Mexico |
 arqu | | |
 Arraiy | Company operating in AI. | |
 Arrakis | Company operating in Biotech & Life Sciences. | |
 Array Labs | Array Labs operates in Hardware & Semiconductors. | |
 Arrcus | Infrastructure & Cloud company. | |
 Arrcus Inc | | |
 ArrePath | Princeton biotechnology company using AI, machine learning and experimental chemistry to discover oral small-molecule drugs. Its platform develops target-specific models to optimize activity and developability together. Initially proven in antibacterial discovery, the company is expanding into immunology and inflammation while seeking partners for its legacy antibiotic programs. | |
 Arris | Arris operates in Hardware & Semiconductors. | |
 Arrive | E-Commerce & Marketplace company. | |
 Arrive (Arrive Recommerce) | Company operating in Logistics & Supply Chain. | |
 Arro | Credit for underserved consumers. | Los Angeles, California |
 Arrow | Arrow operates in Mobility & Transportation. | |
 Arrows | Marketing & Advertising company. | |
 Arsenal Biosciences | | |
 ArsenalBio | ArsenalBio develops programmable T-cell therapies for cancer and autoimmune diseases. Its cell-engineering platform combines synthetic biology, CRISPR-based programming, computation and machine learning to create therapeutic T cells. In August 2026, the company shifted its focus from autologous CAR T treatments for solid tumors to next-generation in vivo CAR T therapies, retaining a smaller core team to advance the new strategy and evaluate opportunities for its technologies and assets. | |
 ARSENALE | Company operating in Defense & Space. | |
 Art of Sport | | |
 Art.com | Art.com operates in E-Commerce & Marketplace. | |
 Arta Finance | | |
 Artemis | Climate & Energy company. | |
 Artemis Health | Artemis Health operates in Healthcare. | |
 ARTHEx Biotech | Valencia biotechnology company developing targeted RNA medicines for genetic neuromuscular disorders. Its investigational lead compound ATX-01 is an anti-microRNA oligonucleotide targeting miR-23b, intended to restore muscleblind-like protein function and correct disrupted RNA splicing in myotonic dystrophy type 1. ATX-01 is being evaluated in the Phase I/IIa ArthemiR clinical trial. ARTHEx’s BOOST-ON platform combines selective oligonucleotides with tissue delivery designed to reach skeletal muscle, heart and brain, and supports additional research programmes in muscular, central nervous system and cardiac disease. The company originated from University of Valencia research. | |
 Arthur AI | Company operating in AI. | |
 Artie | AI company. | San Francisco, CA, US |
 Artifact | | |
 Artifact | | |
 Artificial | Company operating in AI. | |
 Artificial Agency | Company operating in AI. | |
 Artificial Societies | AI simulated marketing technology | UK |
 Artion | SaaS company. | |
 Artios Pharma | Company operating in Biotech & Life Sciences. | |
 Artisan | Manufacturing company. | San Francisco, CA, US |
 Artspace | | |
 Aruba Wireless Networks | | |
 Arva | Climate & Energy company. | |
 ARX | Company operating in Gaming. | |
 ARX Robotics | Company operating in Robotics & Automation. | |
 Aryaka | Company operating in Infrastructure & Cloud. | |
 Aryballe | Hardware & Semiconductors company. | |
 Arysun | Arysun supplies affordable residential solar systems for middle income households in Indonesia, beginning in Greater Jakarta. Its solar starter kits combine panels and inverters sized to household electricity needs, with site surveys, delivery and installation support. The company works with payment partners to lower adoption barriers and aims to expand accessible rooftop solar across Southeast Asia. Its approach focuses on practical household energy savings and appropriately sized equipment rather than large, expensive systems. | |
 Arzooo | Arzooo operates in E-Commerce & Marketplace. | |
 Asaak | Fintech company. | Kampala, UG |
 Asahi Kasei Corp. | Asahi Kasei Corp. is a Japanese diversified company whose businesses span materials, homes and healthcare. Its group develops chemicals, fibers, electronic materials, semiconductors, battery separators and membranes; builds and supplies housing and construction products; and develops pharmaceuticals, life-science technologies and medical devices. It conducts research, manufacturing and commercial operations through distinct operating companies in Japan and international markets. Its corporate venture capital activities invest in and develop partnerships with startups across healthcare, industrial technology, advanced materials and sustainability. The parent corporation is distinct from the Asahi Kasei Ventures investment program and from the Japanese pharmaceutical company Asahi Kasei Therapeutics Corp. The group traces its origins to 1922; the current parent corporation was established in May 1931. | |
 Asahi Kasei Therapeutics Corp. | Asahi Kasei Therapeutics Corp. is the Japanese pharmaceutical operating company of the Asahi Kasei group, formerly named Asahi Kasei Pharma Corporation. It researches, develops, manufactures and markets medicines, with work in orthopedics, critical and intensive care, immunology, urology and central nervous system diseases. Its pharmaceutical corporate venture capital program, established in 2018, invests in early therapeutic pipelines and drug-discovery platforms and supports potential collaborations with biotechnology companies, including Glycomine. The company was established in October 2003 and adopted its current name in April 2026. It is a distinct legal company from Asahi Kasei’s parent corporation and the pharmaceutical operations in the United States and Europe that adopted the shared Asahi Kasei Therapeutics brand in September 2026. | |
 Asana | Asana operates in SaaS. | |
 ASAP Work | Company operating in Consumer. | |
 ASAPP | AI company. | |
 Ascend | Fintech company. | |
 Ascend Advanced Therapies | Ascend is a gene to GMP development partner working to support the next-generation of life-science innovators in bringing advanced therapy products to patients. Our team of experts offer unparalleled insight and collaboration in delivering your products from the bench through the clinic and beyond. | |
 Ascend Arc | | |
 Ascend.io | Ascend.io operates in Fintech. | |
 Ascense Medical | Ascense Medical is a Vienna-based medical-device developer working on elastic vascular and endovascular grafts for aortic disease. Its Complion material platform is designed to mimic the elasticity of a healthy aorta and preserve its Windkessel function: absorbing pressure peaks and maintaining more continuous blood flow. The company is developing knitted polymer grafts with a polyurethane coating for aortic dissection and other aortic repair applications, with the aim of reducing complications associated with conventional stiff grafts. Its current published materials describe product development; a historical target for a European launch in 2026–2027 is a development forecast, rather than proof of regulatory approval or commercial availability. | |
 Ascléa | Berlin clinical AI company founded as x-cardiac and renamed Ascléa in 2026. It develops postoperative complication prediction software and the Clé platform for hospital-controlled deployment of language models and AI workflows, connecting clinical information systems with on-premises or European cloud infrastructure. | |
 Aseon Labs | Robotics & Automation company. | |
 Asepha | Asepha builds AI infrastructure and workflow software for pharmacies. Its agents automate prescription intake and data entry, patient calls, benefits investigation, prior authorization and administrative coordination, while routing clinical questions to pharmacists. Its platform brings pharmacy operations into configurable workflows, including scheduling, reporting, shipment management and patient or provider portals. The company’s CareLink and Care Coordinator tools connect pharmacies with providers, payers and patients to reduce delays in specialty medication access. | |
 ASG Eye Hospital | | |
 asgoodasnew | asgoodasnew is a European re-commerce company for premium consumer electronics, refurbishing and selling smartphones, laptops, cameras and more. The company also operates the buyback platform wirkaufens to extend device lifecycles and promote a circular economy. | 🇩🇪 · Germany |
 Ashby | | |
 Asher Bio | | |
 aSim | | |
 Asimov | | |
 ASKDATA | | |
 AskNicely | Company operating in SaaS. | |
 Askui | Askui operates in AI. | |
 Aslan | Company operating in Cybersecurity. | |
 Aspect Biosystems | Company operating in Biotech & Life Sciences. | |
 Aspen | Enterprise Software company. | |
 Aspen Neuroscience | Autologous iPSC therapy for Parkinson’s. | |
 Aspen Neuroscience | | |
 Aspinity | Aspinity develops analog AI processing chips for always-on sensing devices. Its technology analyzes sensor signals at very low power so systems can detect relevant events before activating more energy-intensive digital processors. | |
 Aspire | Southeast Asia SMB finance operating system. Founded 2018. Singapore. | Singapore |
 Aspire Digital Card | Company operating in Fintech. | |
 Aspora | Indian remittance/banking for diaspora. | |
 Assembled | Assembled operates in HR & Talent. | |
 Assembly | Assembly operates in PropTech. | |
 Assembly | | |
 Assembly | | |
 AssemblyAI | AssemblyAI operates in AI. | |
 Asseta | | |
 Assetbird | Assetbird operates in Fintech. | |
 AssetPlus | Company operating in Fintech. | |
 AssetWatch | Company operating in Manufacturing. | |
 Assort Health | Patient engagement platform that uses specialty-specific voice and agentic AI to automate healthcare call-center workflows such as scheduling, prescription refills, lab results, and other patient-facing tasks. Founded in 2023 by Jeff Liu and Jon Wang. | San Francisco, California |
 Assured | Insurance company. | |
 AssureRx Health | | |
 Astellas Pharma | Astellas Pharma Inc. is a Tokyo-based global life sciences company listed on the Tokyo Stock Exchange (4503). It develops and commercializes therapies in oncology, ophthalmology, urology, immunology and women’s health, and advances drug discovery through genetic regulation, regenerative medicine and other biological platforms. Its Astellas Gene Therapies center develops AAV genetic medicines for rare diseases affecting the eye, central nervous system and neuromuscular system. The company also pursues digital and technology-enabled healthcare through its Rx+ activities. In October2024, Astellas Pharma committed a USD20million equity investment in neurodegenerative gene therapy developer AviadoBio alongside a separate option and license agreement for investigational AVB-101. The operating pharmaceutical company is the named investor in that agreement. | |
 Aster | | |
 Asterix Health | Company operating in Healthcare. | |
 Asteroid | | |
 Astonishing Labs | | |
 Astra | Company operating in Defense & Space. | |
 Astrada | | |
 Astraea | | |
 Astral Systems | Company operating in Climate & Energy. | |
 Astranis | Builds small geostationary communications satellites to deliver affordable broadband to underserved regions. | San Francisco, California |
 Astrix | Astrix operates in Cybersecurity. | |
 Astro | Astro operates in E-Commerce & Marketplace. | |
 Astro | | |
 Astrocade | | |
 Astrocyte Pharmaceuticals | Astrocyte Pharmaceuticals is a clinical-stage biotechnology company in Groton, Connecticut, developing investigational cerebroprotective therapies for traumatic brain injury, concussion, stroke and other neurological conditions. Its lead small molecule, AST-004, is designed to enhance astrocyte energy metabolism through adenosine A1/A3 receptor activation. The company reported completion of enrollment in its Phase 2 STARFAST sports-related concussion trial in September 2026; results and therapeutic benefit remain under investigation. It is also researching oral formulations and additional neurological indications. Co-Founder and CEO William S. Korinek leads a public team of six management members, seven board members and seven clinical and scientific advisers, with overlap across these groups. Co-Founder James D. Lechleiter remains an adviser. Its 2017 seed financing expanded from approximately $1.36 million to over $2.4 million at final closing, followed by a $6 million Series A announced in May 2021, a pre-Series B bridge of over $6 million in August 2023 and a $9.5 million Series B led by DeepWork Capital in September 2026. The company's reported $40 million invested to date includes grants and is not another equity round. NIH records identify four grant project series with approximately $7.365 million in awarded appropriations through fiscal 2026, kept separate from private financing. | |
 AstroForge | AstroForge operates in Defense & Space. | |
 Astrogate Labs | Develops laser communication terminals for satellites, aircraft and terrestrial networks. Its optical technology supports high-speed space-to-ground, intersatellite and mobile links, providing compact communication hardware for satellite constellations and secure strategic networks. | |
 Astrolight | | |
 Astronomer | Astronomer operates in Data & Analytics. | New York, NY, US |
 Astroscale Holdings Inc. | | |
 Astrus | Join Astrus to improve global computation by building AI-powered tools for chip designers. | |
 Asylon Robotics | Asylon Robotics operates in Robotics & Automation. | |
 Asymmetric Security | | |
 Async | Async (previously Podcastle) is an AI-powered platform that lets creators and teams record, edit, and publish video and audio content in a single workflow using AI tools for editing, dubbing, subtitles, and voice generation. | 🇦🇲 · Armenia |
 Async Art | Company operating in Crypto & Web3. | |
 At Bay | Company operating in Cybersecurity. | |
 atai Life Sciences | We are on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments | |
 AtaiBeckley | | |
 Atalanta Therapeutics | Atalanta Therapeutics develops RNA interference medicines for diseases of the central nervous system. Its divalent small interfering RNA (di-siRNA) platform is designed to durably silence disease-associated genes across the brain and spinal cord, including deep brain regions. Its current published pipeline includes programs targeting HTT and MSH3 for Huntington’s disease, NAV1.7 for pain, and undisclosed CNS targets. These are investigational programs; its website places ATL-101 in IND-enabling development. The company also develops partnered programs with Genentech. | |
 Ataraxis AI | AI pathology diagnostics (Ataraxis Breast). FF in $20.4M Series A. | New York, New York |
 Atavistik Bio | Company operating in Biotech & Life Sciences. | |
 Atea Pharmaceuticals | | |
 Athanor | Develops specialty nitrogen chemicals and modular production systems for defence, industrial and high-value applications, combining chemical research with domestic manufacturing capacity. | |
 Athelas | Health technology company offering at-home blood diagnostics and care-management software for patients and providers. | Mountain View, California |
 Athena | | |
 Athenascope | Roblox is a global platform where millions of people gather together every day to imagine, create, and share experiences with each other in immersive, user-generated 3D worlds. | |
 Athenian | Athenian was an engineering insights platform that helped software teams improve delivery by turning GitHub, Jira, and CI/CD data into actionable metrics and workflows. Acquired by the Linux Foundation. | 🇵🇹 · Portugal |
 Athenian | | |
 Athlane | Sports brand marketplace. | Los Angeles, California |
 Athos | | |
 atla | AI company. | |
 Atlantic Therapeutics | Healthcare company. | |
 Atlas | Atlas is a first-of-its-kind brain wearable, powered by breakthrough nanotechnology. Join the waitlist. | |
 Atlas AI | Atlas AI develops geospatial AI software and data products that help organizations understand local socioeconomic conditions, detect changes and forecast demand across global markets. Its platform turns satellite imagery and other location data into analysis-ready geospatial features, production-scale models and developer tools for data scientists. The Aperture product family supports access to hyperlocal indicators and faster monitoring of changes, while applications include infrastructure planning, site selection, market segmentation, logistics, manufacturing forecasts and monitoring vulnerable communities. The company combines economics, earth science and machine learning to provide insights in regions where conventional data are sparse. Founded in 2018 as a public benefit corporation by Stanford researchers Marshall Burke, Stefano Ermon and David Lobell, it is backed by The Rockefeller Foundation, Airbus Ventures and Micron. | |
 Atlas Discovery | Atlas Discovery is an AI-native pharmaceutical company developing autonomous research agents to identify new uses for existing drugs and reduce the work needed to design and run clinical trials. It combines biomedical data, models of patient drug response and agent systems that search evidence, generate hypotheses and predict clinical trial outcomes. Its research includes foundation models trained on preclinical and clinical data. A drug-repurposing candidate for cerebral cavernous malformation is undergoing preclinical testing with Alliance to Cure Cavernous Malformation; this is a research programme, not an approved treatment for that disease. | |
 Atlas Health | Healthcare company. | |
 Atlas Metrics | ESG compliance platform; acquired by Novata. | Berlin, Germany |